Professor Athol Wells specialises in diffuse lung disease.
- Prognostic evaluation in diffuse lung disease using HRCT and pulmonary function tests.
- The definition of relationships between structure and function in diffuse lung disease.
- The definition of disease type and severity in genetic and laboratory studies.
- Studies of new therapies in diffuse lung disease.
Education and background
Professor Wells trained in New Zealand at Green Lane Hospital, Auckland before starting post-graduate studies at Royal Brompton Hospital in 1989.
He makes regular trips outside the UK to speak at major conferences, including symposia at the American Thoracic Society and European Respiratory Society meetings. He also receives many invitations to other congresses around the world to speak at major symposia.
Professor Wells chairs the British Thoracic Society group revising guidelines in diffuse lung disease. He also sits on the American Thoracic Society - European Respiratory Society group revising guidelines in idiopathic pulmonary fibrosis, as well as other joint groups involved in the definition of non-specific interstitial pneumonia, smoking related diffuse lung disease, and acute exacerbations of idiopathic pulmonary fibrosis.
Professor Wells sits on advisory boards for the American Journal of Respiratory and Critical Care Medicine and Thorax, and is the principal editor or co-editor of three books.